Organogenesis Holdings Inc.
NASDAQ:ORGO
3.07 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 433.14 | 450.893 | 468.059 | 338.298 | 260.981 | 193.449 | 0 | 0 |
| Cost of Revenue
| 123.35 | 105.019 | 114.199 | 87.319 | 75.948 | 68.808 | 4.592 | 0.209 |
| Gross Profit
| 309.79 | 345.874 | 353.86 | 250.979 | 185.033 | 124.641 | -4.592 | -0.209 |
| Gross Profit Ratio
| 0.715 | 0.767 | 0.756 | 0.742 | 0.709 | 0.644 | 0 | 0 |
| Reseach & Development Expenses
| 44.38 | 39.762 | 30.742 | 20.086 | 14.799 | 10.742 | 0 | 0 |
| General & Administrative Expenses
| 237.284 | 278.996 | 244.678 | 200.756 | 198.634 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 5.225 | 4.812 | 5.522 | 2.722 | 1.059 | 0 | 0 | 0 |
| SG&A
| 242.509 | 283.808 | 250.2 | 203.478 | 199.693 | 161.961 | 4.592 | 0.209 |
| Other Expenses
| -6.58 | -0.013 | -0.013 | 0.097 | 0.013 | 0.162 | 0 | 0.209 |
| Operating Expenses
| 293.469 | 323.57 | 280.942 | 223.564 | 214.492 | 172.703 | 4.592 | 0.209 |
| Operating Income
| 16.321 | 22.304 | 72.918 | 27.415 | -29.459 | -51.556 | -4.592 | 0.209 |
| Operating Income Ratio
| 0.038 | 0.049 | 0.156 | 0.081 | -0.113 | -0.267 | 0 | 0 |
| Total Other Income Expenses Net
| -5.929 | -2.022 | -9.132 | -8.936 | -10.845 | -5.896 | 2.498 | -0.417 |
| Income Before Tax
| 10.392 | 20.282 | 63.786 | 18.479 | -40.304 | -64.747 | -2.094 | -0.209 |
| Income Before Tax Ratio
| 0.024 | 0.045 | 0.136 | 0.055 | -0.154 | -0.335 | 0 | 0 |
| Income Tax Expense
| 5.447 | 4.75 | -31.116 | 0.53 | 0.15 | 0.084 | -0.053 | -0.44 |
| Net Income
| 4.945 | 15.532 | 94.202 | 17.234 | -40.454 | -64.831 | -2.094 | -0.209 |
| Net Income Ratio
| 0.011 | 0.034 | 0.201 | 0.051 | -0.155 | -0.335 | 0 | 0 |
| EPS
| 0.038 | 0.12 | 0.73 | 0.16 | -0.44 | -0.94 | -0.033 | -0.003 |
| EPS Diluted
| 0.037 | 0.12 | 0.7 | 0.15 | -0.44 | -0.94 | -0.033 | -0.003 |
| EBITDA
| 39.77 | 40.322 | 89.581 | 34.98 | -20.015 | -40.858 | -4.592 | -0.209 |
| EBITDA Ratio
| 0.092 | 0.089 | 0.191 | 0.103 | -0.077 | -0.211 | 0 | 0 |